Boardroom Alpha
Meeting calendar
COO · Annual meeting · Tuesday, April 7, 2026

Cooper Companies Inc

9 nominees · 3 ballot items.

Three proposals: (1) elect nine directors to the Board, (2) ratify KPMG LLP as independent auditor for fiscal 2026, and (3) approve, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers (say-on-pay).

Market cap
$14.3B
1Y TSR
-4.7%
Board grade
C-
Record date
Feb 9, 2026
Filing
DEF 14A
Meeting concluded · Apr 7, 2026

Follow how the vote landed and what changed on Cooper Companies Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect nine directors to the Board to serve one-year terms expiring at the 2027 annual meeting.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2026.

  3. 3

    Advisory Vote on Named Executive Officer Compensation

    ManagementBoard: FOR

    Non-binding, advisory approval of the compensation of the Company’s Named Executive Officers as disclosed in the proxy statement (say-on-pay).

    More detail

    This management proposal asks shareholders to cast a non-binding, advisory vote to approve the Company’s executive compensation program as disclosed in the proxy materials. Management seeks this vote annually to obtain stockholder feedback on pay practices and to demonstrate alignment between executive incentives and stockholder interests. The disclosed program emphasizes pay-for-performance: a large majority of CEO and other NEO target compensation is performance‑based, with a mix of annual cash incentives tied to revenue, non‑GAAP EPS and free cash flow, and long-term equity awards comprising time‑vested options/RSUs and performance stock units tied to multi-year EPS and, beginning in 2026, relative TSR. The Organization & Compensation Committee (OCC) retained an independent consultant, sets rigorous targets, includes clawback provisions and double-trigger change-in-control protections, and modified plan design to add TSR to better align with peers. Management frames recent payouts and program design as evidence of alignment (e.g., strong PSU outcomes and certification at maximum for the 2023–2025 cycle) and highlights governance safeguards such as independent committee oversight, stock ownership guidelines, and limits on perquisites. The vote is advisory and non-binding, but the OCC will consider the outcome when making future compensation decisions and has historically used say-on-pay feedback in program design. The Board recommends a 'FOR' vote, arguing that the program drives long-term value, incentivizes cash generation and profitability, and incorporates market practices and stockholder input. Key governance context includes the Company's recent operational restructuring, improved free cash flow and expanded buyback authorization, which management cites as supporting the compensation outcomes and future design changes. Investors evaluating the proposal should weigh the Company’s demonstrated performance, the strong link between pay and multi-year financial metrics, and the extent to which changes (like adding relative TSR) address investor alignment and market norms.

Director elections

Nominees on the ballot9

Independent
Tenure on this board
10.3 yrs
Also a director at
Beyond Meat Inc (BYND)
Independent
Tenure on this board
1.2 yrs
Also a director at
Limoneira Co (LMNR)Bob's Discount Furniture Inc (BOBS)
Independent
Tenure on this board
2.6 yrs
Also a director at
Elanco Animal Health Inc (ELAN)Lamb Weston Holdings Inc (LW)
Independent
Tenure on this board
3.8 yrs
Also a director at
Mobia Medical Inc (MOBI)
Independent
Tenure on this board
5.6 yrs
Also a director at
Enbridge Inc (ENB)
Independent
Tenure on this board
5.0 yrs
Also a director at
Telix Pharmaceuticals Ltd (TLX)
Not independent
Tenure on this board
8.2 yrs
Also a director at
Evolus Inc (EOLS)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC6.5%12,718,829$909M
2T. Rowe Price Investment Management, Inc.4.6%9,060,177$648M
3STATE STREET CORP4.5%8,768,419$627M
4VANGUARD PORTFOLIO MANAGEMENT LLC4.5%8,721,331$624M
5Capital World Investors3.8%7,414,949$530M
6BROWNING WEST LP3.6%6,979,529$499M
7BlackRock, Inc.3.3%6,360,250$455M
8PRICE T ROWE ASSOCIATES INC /MD/2.6%5,102,064$365M
9KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC2.5%4,914,228$351M
10FRANKLIN RESOURCES INC2.4%4,774,650$341M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Cooper Companies Inc 2026 annual meeting?
Cooper Companies Inc (COO) holds its 2026 annual shareholder meeting on Tuesday, April 7, 2026.
What is the record date for the Cooper Companies Inc 2026 meeting?
The record date for the Cooper Companies Inc 2026 meeting is Monday, February 9, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Cooper Companies Inc's 2026 meeting?
The board is presenting 9 director nominees at the Cooper Companies Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Cooper Companies Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Cooper Companies Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer